LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
23.53
-0.46 (-1.92%)
Mar 20, 2026, 4:00 PM EDT - Market closed
LB Pharmaceuticals Market Cap
LB Pharmaceuticals has a market cap or net worth of $595.29 million as of March 20, 2026.
Market Cap
595.29M
Enterprise Value
284.47M
1-Year Change
n/a
Ranking
Category
Stock Price
$23.53
Market Cap Chart
Since the IPO on September 11, 2025, LB Pharmaceuticals's market cap has increased from $301.50M to $595.29M, an increase of 97.44%. That is a compound annual growth rate of 269.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 595.29M | 5.71% |
| Dec 31, 2025 | 563.16M | 86.78% |
| Sep 11, 2025 | 301.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annexon | 648.41M |
| Alpha Tau Medical | 643.35M |
| Prime Medicine | 637.35M |
| Design Therapeutics | 635.22M |
| Eikon Therapeutics | 633.78M |
| MiMedx Group | 629.92M |
| Tectonic Therapeutic | 603.67M |
| MeiraGTx Holdings | 598.05M |